Advertisement
PMCB 外汇新闻
PharmaCyte Names Joshua Silverman Interim CEO As CEO Kenneth Waggoner Steps Down
Biotechnology company PharmaCyte Biotech, Inc. (PMCB) announced Friday that its CEO Kenneth Waggoner has stepped down from the position as CEO, effective October 6, 2022. The Board has since appointed Joshua Silverman, a member of the Board, as interim CEO.
RTTNews
|
988天前
